Portfolio Update

RNS Number : 0595V

Intl. Biotechnology Trust PLC

18 July 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 30 June 2018

Net Assets	£242m
Net Assets per share	646p
Share price	610p
Total value of unquoted investments	£26m
Total number of portfolio companies	75
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Neurocrine	5.0
Celgene	4.7
Vertex	4.4
Morphosys	4.3
Illumina	3.9
Array	3.6
Genmab	3.6
Regeneron	3.4
Biogen	3.3
Alexion	3.2
	-----------
Total	39.4

Geographical Allocation	% NAV
US & Canada	85
Europe	15
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	89
Unquoted	11
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	34
Mid Cap =USD1-10BN	42
Small Cap <USD1BN	24
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	44
CNS	14
Rare diseases	13
Ophthalmology	6
Inflammation	5
Infectious Diseases	3
Metabolic	2
Medtech	2
Other	11
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

18 JULY 2018

 

END

 

 

PFUBXGDRGBBBGII